(Q34239830)

31 July 2017

1 reference

title

Angiotensin II and atherosclerosis (English)

1 reference

31 July 2017

1 reference

Weiss D

1

1 reference

31 July 2017

Sorescu D

series ordinal

2

1 reference

31 July 2017

Taylor WR

series ordinal

3

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

American Journal of Cardiology

31 July 2017

published in

1 reference

31 July 2017

volume

87

1 reference

31 July 2017

issue

8A

1 reference

31 July 2017

page(s)

25C-32C

1 reference

The multiple actions of angiotensin II in atherosclerosis

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901539-9

Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901539-9

The renin-angiotensin system and fibrinolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901539-9

The critical role of tissue angiotensin-converting enzyme as revealed by gene targeting in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901539-9

Hypothesis regarding the pathophysiological role of alternative pathways of angiotensin II formation in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901539-9

Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901539-9

Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901539-9

Angiotensin II induces vascular cell adhesion molecule-1 expression in rat vasculature: A potential link between the renin-angiotensin system and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901539-9

Monocyte chemoattractant protein-1 expression in aortic tissues of hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901539-9

Chemokine receptor CCR2 expression and monocyte chemoattractant protein-1-mediated chemotaxis in human monocytes. A regulatory role for plasma LDL.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901539-9

The oxidative modification hypothesis of atherogenesis: an overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901539-9

Statin-sensitive dysregulated AT1 receptor function and density in hypercholesterolemic men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901539-9

Angiotensin II induces LOX-1, the human endothelial receptor for oxidized low-density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901539-9

Upregulation of endothelial receptor for oxidized low-density lipoprotein (LOX-1) in cultured human coronary artery endothelial cells by angiotensin II type 1 receptor activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901539-9

The angiotensin-converting enzyme inhibitor, fosinopril, and the angiotensin II receptor antagonist, losartan, inhibit LDL oxidation and attenuate atherosclerosis independent of lowering blood pressure in apolipoprotein E deficient mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901539-9

Losartan inhibits cellular uptake of oxidized LDL by monocyte-macrophages from hypercholesterolemic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901539-9

Cellular and molecular mechanisms of endothelial cell dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901539-9

Enhanced atherosclerosis and kidney dysfunction in eNOS(-/-)Apoe(-/-) mice are ameliorated by enalapril treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901539-9

Interactions between nitric oxide and lipid oxidation pathways: implications for vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901539-9

Superoxide and peroxynitrite in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901539-9

Effects of long-term nitroglycerin treatment on endothelial nitric oxide synthase (NOS III) gene expression, NOS III-mediated superoxide production, and vascular NO bioavailability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901539-9

Vasodilator-stimulated phosphoprotein serine 239 phosphorylation as a sensitive monitor of defective nitric oxide/cGMP signaling and endothelial dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901539-9

Tetrahydrobiopterin improves endothelium-dependent vasodilation in chronic smokers : evidence for a dysfunctional nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901539-9

NAD(P)H oxidase: role in cardiovascular biology and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901539-9

Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901539-9

Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901539-9

p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901539-9

Role of NADH/NADPH oxidase-derived H2O2 in angiotensin II-induced vascular hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901539-9

p38 Mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901539-9

Reactive oxygen species mediate the activation of Akt/protein kinase B by angiotensin II in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901539-9

Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901539-9

Angiotensin induces inflammatory activation of human vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901539-9

Interleukin-6 can prime THP-1 macrophages for enhanced production of tumor necrosis factor-α in response to LPS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901539-9

Expression of NADH/NADPH oxidase p22phox in human coronary arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901539-9

A variant of p22(phox), involved in generation of reactive oxygen species in the vessel wall, is associated with progression of coronary atherosclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901539-9

Polymorphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901539-9

Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901539-9

Essential hypertension: renin and aldosterone, heart attack and stroke.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901539-9

The pathophysiology of hypertension: the importance of angiotensin II in cardiovascular remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901539-9

Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901539-9

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901539-9

Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901539-9

Antiatherosclerotic and antioxidative effects of captopril in apolipoprotein E-deficient mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901539-9

Inhibition of early atherogenesis by losartan in monkeys with diet-induced hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901539-9

Increased NADH-Oxidase–Mediated Superoxide Production in the Early Stages of Atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901539-9

Angiotensin II-induced hypertension accelerates the development of atherosclerosis in apoE-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901539-9

Angiotensin II induction of osteopontin expression and DNA replication in rat arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901539-9

Angiotensin II stimulates intercellular adhesion molecule-1 (ICAM-1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901539-9

Angiotensin II-induced leukocyte adhesion on human coronary endothelial cells is mediated by E-selectin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901539-9

Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-kappa B transcription factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901539-9

Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901539-9

Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901539-9

Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901539-9

Abnormal renal function and autoregulation in essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901539-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9149(01)01539-9

1 reference

31 July 2017

1 reference